All In MedTech

FDA Clearance Tracker · P130008-S029

Inspire Upper Airway Stimulation Therapy

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 11, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P130008-S029
Device name
Inspire Upper Airway Stimulation Therapy
Applicant location
Maple Grove, MN
Received
Nov 14, 2017
Decided
May 11, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P130008

Device type

Device class
Class III

Every decision under product code MNQ

FDA's approval statement

As written in FDA's record.

Approval for updates to the labeling with the results of the Extended Follow Up of the Premarket Cohort post approval study.

Source documents

Other decisions for Inspire Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.